| Not Yet Recruiting | Tumor-Derived Extracellular Vesicles for Noninvasive Molecular Classification of Kidney Cancer NCT07243067 | Mayo Clinic | — |
| Not Yet Recruiting | CD70.CAR for CD70+ Lymphoma, Myeloma and Solid Tumors NCT07297160 | Baylor College of Medicine | Phase 1 |
| Recruiting | Post-immunotherapy Nephrectomy for Metastatic Kidney Cancer After Complete or Major Response to Systemic Thera NCT06882486 | Institut Paoli-Calmettes | N/A |
| Recruiting | A Phase 1b Study of HC-7366, an Agonist of ISR With Immunotherapy in Kidney Cancer (SHARK) NCT07401875 | M.D. Anderson Cancer Center | Phase 1 |
| Recruiting | Pre-NEOSHIFT-RCC: Neoadjuvant HIF-Inhibitor Immunotherapy in RCC NCT07397611 | Dana-Farber Cancer Institute | Phase 2 |
| Withdrawn | A Novel Haemostatic Agent for Robotic Partial Nephrectomy NCT07284953 | The Royal Wolverhampton Hospitals NHS Trust | N/A |
| Recruiting | EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors NCT07410676 | Essen Biotech | Phase 1 / Phase 2 |
| Withdrawn | Acarbose in Combination With Standard Therapy in Metastatic Renal Cell Carcinoma (RCC) NCT05487859 | University of Alabama at Birmingham | Phase 2 |
| Recruiting | Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients NCT06138067 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | N/A |
| Recruiting | A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma NCT07123090 | Stephanie Berg | Phase 2 |
| Not Yet Recruiting | Tumor Rupture During Robotic Partial Nephrectomy NCT07065825 | Azienda Ospedaliera Universitaria Integrata Verona | — |
| Active Not Recruiting | 177LuPSMA in Renal Cell Carcinoma NCT06964958 | Dana-Farber Cancer Institute | Phase 2 |
| Recruiting | Assessing Financial Toxicity Using the PROFFIT Questionnaire in Patients Treated With Mini-invasive Approach f NCT06955910 | Istituto Oncologico Veneto IRCCS | — |
| Recruiting | Primary Tumor Ablation and Outcome in Metastatic Renal Cell Carcinoma Treated With Immunotherapy Combinations. NCT06903312 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Phase 4 |
| Not Yet Recruiting | Proteomic Analysis of Patients Undergoing Bariatric Surgery NCT06787807 | Universidade Federal de Pernambuco | N/A |
| Recruiting | A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With S NCT06682793 | A2 Biotherapeutics Inc. | Phase 1 / Phase 2 |
| Recruiting | Cabozantinib and Nivolumab Among Older Patients With Renal Cell Carcinoma NCT06934057 | Gustave Roussy, Cancer Campus, Grand Paris | Phase 4 |
| Recruiting | Designing Visual Tools to Enhance Cancer Surgeon Decision-making NCT06965192 | UNC Lineberger Comprehensive Cancer Center | N/A |
| Recruiting | Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies NCT07327489 | Elephas | — |
| Recruiting | Prospective Evaluation of Cornerstone Robotics Sentire Surgical System in Major Gastrointestinal and Urologic NCT06926374 | Chinese University of Hong Kong | N/A |
| Recruiting | Brodalumab in the Treatment of Immune-Related Adverse Events NCT06673329 | Brian Henick, MD | Phase 1 |
| Recruiting | Rein 3D PRINT MECHANICS NCT06525831 | University Hospital, Bordeaux | N/A |
| Not Yet Recruiting | Study on the Efficacy and Mechanism of METTL3 Peptide Inhibitors in Enhancing Anti-tumor Immune Response by Re NCT06762925 | Xijing Hospital | — |
| Recruiting | Study of Post-operative Complications After Laparoscopic Outpatient Nephrectomy NCT06532422 | GCS Ramsay Santé pour l'Enseignement et la Recherche | — |
| Enrolling By Invitation | Drug Screening Using Novel IMD in Renal Cell Carcinoma NCT05700461 | Oliver Jonas | Phase 1 |
| Recruiting | Ivonescimab in the Treatment of Multiple Advanced Tumors NCT06683846 | Fudan University | Phase 2 |
| Completed | Enhanced Assistance During Radiotherapy for Unmet Essential Needs NCT06582849 | Washington University School of Medicine | N/A |
| Recruiting | A Study of VET3-TGI in Patients With Solid Tumors NCT06444815 | KaliVir Immunotherapeutics | Phase 1 |
| Not Yet Recruiting | A Prospective Registry Study of Stereotactic Ablative Radiotherapy (SABR) for Oligometastatic/Oligometastatic NCT06585878 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | N/A |
| Not Yet Recruiting | Vorolanib Combined With Cadonilimab in the Treatment of Untreated Advanced RCC Patients NCT06577961 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Phase 1 / Phase 2 |
| Recruiting | A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy NCT06362369 | 7 Hills Pharma, LLC | Phase 1 / Phase 2 |
| Recruiting | Planning Operative Strategy Using a Digital Renal Artery Clamping Tool NCT06536439 | University Hospital, Ghent | N/A |
| Terminated | Prospective Evaluation of AI R&D Tool for Patient Stratification: a Trial for Renal Immuno-oncology Model Expe NCT06264479 | Ourotech, Inc. | — |
| Active Not Recruiting | Integrated Actionable Aging Assessment for Cancer Patients Pilot NCT05871008 | University of Colorado, Denver | N/A |
| Recruiting | Resection or Ablation of Small Kidney Tumors NCT06278506 | Karolinska University Hospital | N/A |
| Recruiting | FMT in Checkpoint Inhibitor-mediated Diarrhea and Colitis NCT06206707 | University of Aarhus | N/A |
| Recruiting | Proteomic Guided First-line Precision Treatment of Renal Clear Cell Carcinoma NCT06211790 | Fudan University | Phase 2 |
| Recruiting | MRI Guided Radiotherapy and Radiobiological Data: the ISRAR Database (Irm Sequences for Radiobiological Adapta NCT06041555 | Hospices Civils de Lyon | — |
| Active Not Recruiting | The HistoSonics Edison™ System for Treatment of Primary Solid Renal Tumors Using Histotripsy (#HOPE4KIDNEY) NCT05820087 | HistoSonics, Inc. | N/A |
| Recruiting | Neoadjuvant Pembrolizumab and Axitinib in Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus NCT05969496 | University of Colorado, Denver | Phase 2 |
| Unknown | A Study of the Clinical Application of [18F]RCCB6 and [68Ga]Ga-NOTA-RCCB6 PET/CT Imaging in the Diagnosis of C NCT06148220 | Huashan Hospital | N/A |
| Recruiting | NSAID Use After Robotic Partial Nephrectomy NCT05842044 | University of Miami | Phase 2 |
| Recruiting | A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest NCT05899361 | Dana-Farber Cancer Institute | N/A |
| Terminated | A Phase 1 Clinical Trial of AUR106 in Patients With Relapsed Advanced Malignancies NCT05861947 | Aurigene Discovery Technologies Limited | Phase 1 |
| Terminated | Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccR NCT05935748 | NiKang Therapeutics, Inc. | Phase 2 |
| Active Not Recruiting | Randomized Clinical Trial Aimed at Comparing Unclamped Robotic Partial Nephrectomy With or Without Renorrhaphy NCT06846112 | Regina Elena Cancer Institute | N/A |
| Recruiting | The Role of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma in Immuno-oncology Era: SEVURO-CN Tri NCT05753839 | Yonsei University | N/A |
| Recruiting | Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform NCT05520099 | Elephas | — |
| Recruiting | A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors NCT05961111 | Shanghai Yunying Medical Technology | EARLY_Phase 1 |
| Recruiting | Preop Laxatives in Robotic Urologic Surgery NCT05805436 | Chad R. Tracy | Phase 4 |
| Active Not Recruiting | A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid NCT05864144 | Sensei Biotherapeutics, Inc. | Phase 1 / Phase 2 |
| Recruiting | Evaluation of Skin Health and QoL in Pts Receiving Anti-PD1/PDL1/CTLA4 or CDK Inhibitors. NCT05878964 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Active Not Recruiting | Linking In With Advice and Supports for Men Impacted by Metastatic Cancer NCT05946993 | University College Cork | N/A |
| Withdrawn | GI Organ Tracking Via Balloon Applicators NCT05471401 | Washington University School of Medicine | N/A |
| Active Not Recruiting | Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors NCT05704985 | DEKA Biosciences | Phase 1 |
| Recruiting | Measuring Oncological Value of Exercise and Statin NCT05796973 | Tampere University Hospital | Phase 3 |
| Completed | The HistoSonics Investigational System for Treatment of Primary Solid Renal Tumors Using Histotripsy NCT05432232 | HistoSonics, Inc. | N/A |
| Unknown | A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (V NCT05708950 | Kineta Inc. | Phase 1 / Phase 2 |
| Recruiting | LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology NCT05184790 | University of Sydney | — |
| Recruiting | Investigation of Differential Biology of Benign and Malignant Renal Masses Using Advanced Magnetic Resonance I NCT06016075 | University of Cambridge | N/A |
| Recruiting | Renal Cancer Monitoring Based on ctDNA Methylomics: A Prospective Cohort Study (MEMORY Study) NCT05917106 | Jinling Hospital, China | — |
| Active Not Recruiting | Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO) NCT05696444 | Medtronic - MITG | N/A |
| Unknown | Frequency, Clinical Phenotype and Genetic Analysis of Heritable Kidney Cancer Syndromes NCT05534854 | RenJi Hospital | — |
| Completed | Robot-assisted Partial Nephrectomy With and Without Mixed Reality (REALITATEM Study) NCT06903260 | Hospital Moinhos de Vento | Phase 3 |
| Completed | Rib Removal and Pain in Partial Nephrectomy NCT06543095 | TC Erciyes University | — |
| Recruiting | Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O) NCT05403177 | University Health Network, Toronto | — |
| Completed | A Study to Describe the Kidney Cancer Patient Population Treatment, and Results in the Hospital District of So NCT05363072 | Pfizer | — |
| Completed | Percutaneous Cryoablation of Central Kidney Tumours With Temporary Renal Artery Occlusion NCT05461027 | University Hospital, Strasbourg, France | — |
| Terminated | A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tu NCT05070247 | Takeda | Phase 1 / Phase 2 |
| Active Not Recruiting | Study of Nivolumab in Combination With 177Lu-girentuximab for Kidney Cancer NCT05239533 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | Safety and Preliminary Efficacy of Meldonium in Patients with Metastatic Renal Cell Carcinoma and Treatment-as NCT06648902 | Kidney Cancer Research Bureau | Phase 1 / Phase 2 |
| Recruiting | International REgistry of COnservative or Radical Treatment of Localized Kidney Tumors NCT05363657 | Azienda Ospedaliero-Universitaria Careggi | — |
| Completed | CARINAE for Stress Relief in Perioperative Care NCT05184725 | Adhera Health, Inc. | N/A |
| Unknown | Virtual 3D Modelling for Improved Surgical Planning of Robotic-assisted Partial Nephrectomy NCT05109182 | Innersight Labs Ltd | N/A |
| Completed | Primary Care-Based Follow-up of Cancer Survivors of the Prostate and Kidney NCT06214000 | University Hospital, Strasbourg, France | — |
| Unknown | Patient Reported Outcomes by Patients With Metastatic Renal Cell Carcinoma NCT05135832 | Herlev and Gentofte Hospital | N/A |
| Unknown | Prospective Validation of the Prognostic Value of Long Non-coding MFI2-AS1 RNA in Localized Clear Cell Kidney NCT04946266 | University Hospital, Strasbourg, France | — |
| Terminated | A Study of NKT2152, a HIF2α Inhibitor, in Patients With Advanced Clear Cell Renal Cell Carcinoma NCT05119335 | NiKang Therapeutics, Inc. | Phase 1 / Phase 2 |
| Recruiting | Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit) NCT05056077 | University of California, San Francisco | N/A |
| Active Not Recruiting | Reduction of Allogenic Blood Transfusion in Locally Advanced Kidney Cancer NCT04922307 | Vanderbilt University Medical Center | N/A |
| Recruiting | Ex VIvo DEtermiNed Cancer Therapy NCT05231655 | Sheffield Teaching Hospitals NHS Foundation Trust | — |
| Completed | DS Titanium Ligation Clip in Urology (Prostatectomy and Nephrectomy) NCT04869462 | Aesculap AG | — |
| Completed | The Registry of Oncology Outcomes Associated With Testing and Treatment NCT04028479 | Taproot Health | — |
| Completed | DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study) NCT04825834 | Delfi Diagnostics Inc. | — |
| Not Yet Recruiting | Comparison of Surgery and Active Surveillance in the Treatment of Bosniak III Renal Cysts NCT04670887 | Helsinki University Central Hospital | N/A |
| Active Not Recruiting | KidneyCare Cohort Study (KCC-S) NCT06898632 | University of Utah | — |
| Unknown | Contrast Ultrasound Dispersion Imaging (CUDI) as a Diagnostic Modality in the Diagnosis of Renal Cell Carcinom NCT04669613 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | N/A |
| Completed | Serial Ultrasound in Metastatic Renal Cell Carcinoma (mRCC) NCT04508725 | Stanford University | N/A |
| Completed | Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients NCT04604158 | Gillian Gresham | N/A |
| Recruiting | TDM for Optimized Outcome in Patients With mRCC. NCT04659343 | Niels Fristrup | — |
| Completed | Contrast-Enhanced Ultrasound for Kidney Cancer Subtyping and Staging NCT04021238 | UNC Lineberger Comprehensive Cancer Center | Phase 2 |
| Recruiting | (3D) Ultrasound Imaging Liver and Kidney NCT03844399 | Western University, Canada | — |
| Terminated | Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors NCT04383210 | Elevation Oncology | Phase 2 |
| Completed | Behavioral Weight Loss Program for Cancer Survivors in Maryland NCT04534309 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | N/A |
| Completed | A Prospective Post-Market Study to Evaluate the Clinical Utility of IRIS, a Three-dimensional (3-D) Anatomical NCT04329767 | Intuitive Surgical | — |
| Completed | Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S NCT04430842 | Quadriga Biosciences, Inc. | Phase 1 |
| Completed | Participant Reported Outcomes and Treatment Experiences in Kidney Cancer NCT04472663 | Bristol-Myers Squibb | — |
| Recruiting | Deferred Cytoreductive Nephrectomy in Synchronous Metastatic Renal Cell Carcinoma: The NORDIC-SUN-Trial NCT03977571 | Niels Fristrup | N/A |
| Active Not Recruiting | Perioperative Lenvatinib With Pembrolizumab in Patients With Locally Advanced Nonmetastatic Clear Cell Renal C NCT04393350 | Emory University | Phase 2 |
| Recruiting | CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase Inhibition NCT04322955 | Mark Stein | Phase 2 |
| Completed | Cellular Immunity and Renal Cell Cancer NCT04377113 | Clinical Hospital Center Rijeka | — |
| Completed | To Establish a Reproducible Organoid Culture Model With Human Kidney Cancer NCT04342286 | Chinese University of Hong Kong | — |
| Completed | Talazoparib and Axitinib for People With Previously Treated Advanced Kidney Cancer NCT04337970 | Memorial Sloan Kettering Cancer Center | Phase 1 / Phase 2 |
| Withdrawn | Trial of NanoDoce Intratumoral Injection in Renal Cell Carcinoma NCT04260360 | NanOlogy, LLC | Phase 1 |
| Active Not Recruiting | Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Healt NCT04000880 | University of Alabama at Birmingham | N/A |
| Unknown | Breathomics as Predictive Biomarker for Checkpoint Inhibitor Response NCT04146064 | University Health Network, Toronto | — |
| Terminated | ESP Block for Laparoscopic Nephrectomy Surgeries NCT04085237 | McMaster University | N/A |
| Completed | Uro-DNA Collection for Expanded Genome-Wide Association Study (GWAS) of Renal Cell Carcinoma (RCC) NCT04222374 | University Hospital, Bordeaux | — |
| Completed | Effect of Papaverine on Renal Artery Blood Flow Volume NCT04162834 | Asan Medical Center | Phase 4 |
| Recruiting | An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Bi NCT04623502 | University of Texas Southwestern Medical Center | N/A |
| Not Yet Recruiting | Impact of Tumour 1q Gain in French Pediatric and Young Adult Patients With Renal Tumours NCT04005820 | Assistance Publique Hopitaux De Marseille | N/A |
| Recruiting | Study of Olaparib in Metastatic Renal Cell Carcinoma Patients With DNA Repair Gene Mutations NCT03786796 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 2 |
| Active Not Recruiting | NeoVax Plus Ipilimumab in Renal Cell Carcinoma NCT02950766 | Patrick Ott, MD, PhD | Phase 1 |
| Terminated | Effect of Perioperative Intravenous Lidocaine Infusion in Robotic-Assisted Urologic Surgery NCT03824808 | University of Missouri-Columbia | Phase 4 |
| Recruiting | Renal Cancer Detection Using Convolutional Neural Networks NCT03857373 | Nessn Azawi | — |
| Recruiting | Genetic Evaluation of Renal Cell Carcinoma; Predicting Biomarkers for Renal Cell Carcinoma NCT03414827 | Zealand University Hospital | — |
| Completed | Identification of Predictive Gene Expression Profile of Sunitinib Response in Metastatic Clear Cell Renal Carc NCT04415697 | Barretos Cancer Hospital | — |
| Active Not Recruiting | A Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cel NCT03634540 | Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | Phase 2 |
| Completed | A Study to Observe the Onset of Immune-related Adverse Reactions in Patients With Non-surgical or Renal Cell C NCT03663946 | Bristol-Myers Squibb | — |
| Completed | Study Comparing Denosumab With Standard Treatment in Urothelial Cancer Patients With Bone Metastases NCT03520231 | University Health Network, Toronto | Phase 2 |
| Completed | Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors NCT03662204 | Exact Sciences Corporation | — |
| Terminated | Effects of a Neuroscience-based Technique on Cancer Patients Announced of a Palliative Disease Progression and NCT03652298 | Centre Oscar Lambret | Phase 2 |
| Active Not Recruiting | HERV-E TCR Transduced Autologous T Cells in People With Metastatic Clear Cell Renal Cell Carcinoma NCT03354390 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 1 |
| Terminated | Optimizing the Management of Patients With Oral Therapy NCT03623490 | Centre Georges Francois Leclerc | N/A |
| Completed | Study of Nivolumab for Advanced Cancers in India NCT03444766 | Bristol-Myers Squibb | Phase 4 |
| Recruiting | Microwave Ablation for Treatment of Small Renal Tumors and Primary and Secondary Liver Neoplasms NCT03981497 | Francesco De Cobelli | — |
| Completed | Safety and Effectiveness of Nivolumab in Recurring Kidney Cancer Participants NCT03568435 | Bristol-Myers Squibb | — |
| Completed | Study of the Concentration-effect Relationship of Nivolumab in Patients With Kidney or Lung Cancer NCT03433534 | University Hospital, Tours | — |
| Active Not Recruiting | Non-Interventional Study (NIS) of Nivolumab With or Without Ipilimumab in Participants With Advanced Kidney Ca NCT03455452 | Bristol-Myers Squibb | — |
| Active Not Recruiting | Study of Durvalumab and Guadecitabine in Advanced Kidney Cancer NCT03308396 | Ajjai Alva, MD | Phase 1 / Phase 2 |
| Withdrawn | REDECT 2: REnal Masses: Pivotal Trial to DEteCT Clear Cell Renal Cell Carcinoma With PET/CT NCT01762592 | Heidelberg Pharma AG | Phase 3 |
| Unknown | Development of Diagnostics and Treatment of Urological Cancers NCT02994758 | Helsinki University Central Hospital | N/A |
| Completed | Using Virtual Reality (VR) Models for Preoperative Planning NCT03334344 | Ceevra, Inc. | N/A |
| Terminated | Reconstitution of a Human Immune System in a Patient Derived Xenograft (PDX) Model of Genitourinary (GU) Cance NCT03134027 | Duke University | — |
| Unknown | Evaluation of a Promising New Combination of Protein Kinase Inhibitors on Organotypic Cultures of Human Renal NCT03571438 | University Hospital, Grenoble | N/A |
| Recruiting | Liquid Biopsy Evaluation and Repository Development at Princess Margaret NCT03702309 | University Health Network, Toronto | — |
| Completed | Project HERO: Health Empowerment & Recovery Outcomes NCT03345563 | Rutgers, The State University of New Jersey | N/A |
| Active Not Recruiting | Predictive Impact of MMP2 and MMP9 Levels for Patients With Metastatic Kidney Cancer Treated With Anti-angioge NCT03185039 | Institut Paoli-Calmettes | N/A |
| Withdrawn | Sunitinib Followed by Avelumab or the Reverse for Metastatic Renal Cell Carcinoma NCT03035630 | Guru Sonpavde | Phase 2 |
| Completed | Use of Human Dehydrated Amnion/Chorion (DHACM) Allograft in Partial Nephrectomy NCT03323021 | MiMedx Group, Inc. | N/A |
| Completed | Interleukin-2 and Pembrolizumab for Metastatic Kidney Cancer NCT02964078 | H. Lee Moffitt Cancer Center and Research Institute | Phase 2 |
| Completed | SBRT (Stereotactic Body Radiation Therapy) in Combination With Nivolumab/Ipilimumab in Renal Cell Carcinoma (R NCT03065179 | University of Texas Southwestern Medical Center | Phase 2 |
| Completed | Does the Use of Hemostatic Clips During the Tumor Resection Step Reduce Blood Loss During Robot-assisted Parti NCT04388917 | Centre Hospitalier Universitaire de Nice | — |
| Completed | Neoadjuvant MEDI 4736 +/- Tremelimumab in Locally Advanced Renal Cell Carcinoma NCT02762006 | Moshe Ornstein | Phase 1 |
| Active Not Recruiting | A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001) NCT02974738 | Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | Phase 1 |
| Unknown | Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-line Sunitinib: a Phase I/II NCT02446795 | Consorzio Oncotech | Phase 1 / Phase 2 |
| Terminated | MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors NCT02669914 | Washington University School of Medicine | Phase 2 |
| Unknown | Safety and Feasibility of IRE for SRMs NCT02828709 | Dr. Prof. M.P. Laguna Pes | Phase 2 |
| Unknown | A Study of DC-CIK Immunotherapy in the Treatment of Solid Tumors NCT04476641 | Sun Yat-sen University | Phase 2 |
| Completed | Expectations and Priorities of Elderly Patients for a First Medical Treatment for Cancer NCT02821793 | Institut Bergonié | — |
| Active Not Recruiting | Random Evaluation of Patients Who Have Had Laparoscopic Partial Nephrectomy NCT04120805 | University of Chicago | N/A |
| Completed | Study of PSMA-targeted 18F-DCFPyL PET/CT in the Evaluation of Patients With Renal Cell Carcinoma NCT02687139 | Johns Hopkins University | N/A |
| Completed | Survivorship Promotion In Reducing IGF-1 Trial NCT02431676 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 2 |
| Recruiting | Protocol Active Surveillance Small Renal Masses (SRMs) NCT03804320 | IRCCS San Raffaele | N/A |
| Terminated | Nephrotoxicity Associated to Parenchymal Clamping During Partial Nephrectomy Using a Microdialysis Technique NCT02511275 | Centre Hospitalier Universitaire de Saint Etienne | N/A |
| Active Not Recruiting | A Phase 1, Dose-Escalation Trial of PT2385 Tablets In Patients With Advanced Clear Cell Renal Cell Carcinoma ( NCT02293980 | Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | Phase 1 |
| Unknown | A Prospective Study of Clinical Factors Affecting Disease Progression and Treatment Results of Patients With T NCT02186925 | Meir Medical Center | — |
| Completed | Sunitinib Scheduling in Metastatic Renal Cell Carcinoma (mRCC) NCT02060370 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Personal Web Page In Clinical Trial Participant Education NCT03887091 | Dana-Farber Cancer Institute | N/A |
| Completed | A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combinati NCT02118337 | MedImmune LLC | Phase 1 / Phase 2 |
| Completed | Study of Ferumoxytol Enhanced MRI for Detecting Lymph Node Metastases in Prostate, Bladder, and Kidney Cancers NCT02141490 | National Cancer Institute (NCI) | Phase 2 |
| Completed | RObotic PArtial Nephrectomy National Study NCT03292549 | University Hospital, Bordeaux | — |
| Completed | Perfusion Scanning's for Kidney Tumors NCT01971905 | Nessn Azawi | — |
| Completed | A Phase 2 Study of the MET Kinase Inhibitor INC280 in Papillary Renal Cell Cancer NCT02019693 | National Cancer Institute (NCI) | Phase 2 |
| Unknown | Efficacy and Safety of IRE for RMs NCT02298608 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Phase 1 / Phase 2 |
| Recruiting | Integrated Cancer Repository for Cancer Research NCT02012699 | University of Nebraska | — |
| Completed | Carfilzomib in Refractory Renal Cell Carcinoma (RCC) NCT01775930 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Contrast Enhanced Intraoperative Ultrasound for Detection and Characterization of Renal Mass Undergoing Open P NCT01894607 | M.D. Anderson Cancer Center | N/A |
| Unknown | Optical Biopsy to Improve the Diagnosis of Kidney Cancer NCT02073110 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | — |
| Completed | Engagement of Patients With Advanced Cancer NCT02966509 | Stanford University | N/A |
| Completed | Tumor Collection From Routine Nephrectomy for Subjects With Advanced Stage RCC NCT02143492 | Argos Therapeutics | — |
| Completed | At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurolo NCT01931644 | Sanguine Biosciences | — |
| Completed | Open-label Pilot Evaluating Renal Lesions w/ Contrast-enhaced US in Patients w/ Renal Cancer NCT01751529 | UNC Lineberger Comprehensive Cancer Center | EARLY_Phase 1 |
| Completed | Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC) NCT01392183 | M.D. Anderson Cancer Center | Phase 2 |
| Unknown | Renal Hypothermia During Partial Nephrectomy NCT01529658 | Ottawa Hospital Research Institute | N/A |
| Completed | Mind-Body Health in Uro-Oncology: Research Study NCT03852030 | Northwestern University | N/A |
| Completed | Sorafenib Tosylate and Hypoxia-Activated Prodrug TH-302 in Treating Patients With Advanced Kidney Cancer or Li NCT01497444 | Alliance for Clinical Trials in Oncology | Phase 1 |
| Completed | Studying Biomarkers in Samples From Younger Patients With Wilms Tumor NCT01576198 | Children's Oncology Group | — |
| Completed | Studying Genes Using Cord Blood and Placenta Samples From Relatively Healthy Newborns and Samples From Younger NCT01576211 | Children's Oncology Group | — |
| Completed | Biomarkers in Urine Samples From Patients With Wilms Tumor NCT01550393 | Children's Oncology Group | — |
| Completed | Studying Biomarkers in Samples From Young Patients With Rhabdoid Tumors NCT01544569 | Children's Oncology Group | — |
| Completed | Studying Gene Expression in Samples From Patients With Rhabdoid Tumors NCT01553175 | Children's Oncology Group | — |
| Completed | Studying Biomarkers in Samples From Younger Patients With Wilms Tumor NCT01542333 | Children's Oncology Group | — |
| Terminated | Hydroxyethyl Starch and Renal Function After Laparoscopic Nephrectomy NCT01486550 | Regional Hospital Holstebro | Phase 4 |
| Recruiting | UroCCR Database: French Research Network for Kidney Cancer -UroCCR NCT03293563 | University Hospital, Bordeaux | — |
| Completed | Biomarkers in Blood and Tumor Tissue Samples From Patients With Wilms Tumor NCT01314391 | Children's Oncology Group | — |
| Terminated | Assessing Everolimus in Fist Line Treatment on Patients With Metastatic Kidney Cancer NCT01888042 | Gustave Roussy, Cancer Campus, Grand Paris | Phase 2 |
| Completed | Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing Can NCT01353300 | Children's Oncology Group | — |
| Completed | S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery NCT01120249 | SWOG Cancer Research Network | Phase 3 |
| Terminated | Everolimus (RAD001) For Advanced Renal Cell Carcinoma (RCC) Before Kidney Removal NCT00831480 | Linda C. Higgins | Phase 2 |
| Completed | Neoadjuvant Axitinib in Locally Advanced Renal Cell Carcinoma (RCC) NCT01263769 | M.D. Anderson Cancer Center | Phase 2 |
| Active Not Recruiting | Sequential Two-agent Assessment in Renal Cell Carcinoma Therapy: The START Trial NCT01217931 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Expanded Phase I Pazopanib and Everolimus in Advanced Solid Tumors and Previously Treated Advanced Urothelial NCT01184326 | Dana-Farber Cancer Institute | Phase 1 |
| Terminated | Efficacy and Safety of Bevacizumab/Temsirolimus Combination to Treat Advanced Renal Cell Carcinoma NCT01264341 | Hellenic Cooperative Oncology Group | Phase 2 |
| Completed | Sunitinib Malate With or Without Gemcitabine Hydrochloride in Treating Patients With Advanced Kidney Cancer Th NCT01164228 | ECOG-ACRIN Cancer Research Group | Phase 2 |
| Terminated | Everolimus Versus Sunitinib in Non-Clear Cell Renal Cell Carcinoma NCT01185366 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Cardiac Arrhythmias in Patients Undergoing Kidney Cancer Surgery Depending on the Anaesthesia Method NCT02988219 | Medical University of Warsaw | Phase 4 |
| Unknown | Perspective Evaluation of Hormones Involved in Serum Phosphate Homeostasis in Patients With Metastatic Renal C NCT01230697 | University of Turin, Italy | — |
| Completed | Sunitinib Plus Temsirolimus in Patients With Renal Cell Cancer (RCC) NCT01122615 | M.D. Anderson Cancer Center | Phase 1 |
| Unknown | Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer NCT01099423 | European Organisation for Research and Treatment of Cancer - EORTC | Phase 3 |
| Terminated | Study of Pazopanib and Ixabepilone in Patients With Solid Tumors NCT01012362 | Masonic Cancer Center, University of Minnesota | Phase 1 |
| Completed | Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium NCT00896454 | Amgen | Phase 2 |
| Terminated | Determining the Lymphokine Activated Killer (LAK) Cytotoxicity Present in Patients Undergoing Interleukin-2 Th NCT01068470 | Loma Linda University | — |
| Completed | Biomarkers in Tumor Tissue Samples From Young Patients With Very Low Risk Wilms Tumors NCT01004783 | Children's Oncology Group | — |
| Completed | Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblast NCT01048892 | Children's Oncology Group | Phase 1 |
| Completed | 177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors NCT00967577 | Weill Medical College of Cornell University | Phase 1 |
| Completed | Acceptability of Less Harmful Alternatives to Cigarettes NCT00957424 | Roswell Park Cancer Institute | N/A |
| Completed | Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carc NCT00782275 | Beth Israel Deaconess Medical Center | Phase 2 |
| Completed | Sunitinib in Treating Patients With Kidney Cancer That Has Spread to the Brain NCT00814021 | Institut Claudius Regaud | Phase 2 |
| Terminated | Phase 1/2 Study of Metastatic Renal Cancer Using T-Cells Transduced With a T-Cell Receptor Which Recognizes TR NCT00923390 | National Cancer Institute (NCI) | Phase 1 |
| Terminated | Sunitinib and Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer NCT00853125 | Rutgers, The State University of New Jersey | Phase 2 |
| Completed | Sunitinib Malate in Treating Patients With Kidney Cancer NCT00943839 | Centre Antoine Lacassagne | N/A |
| Terminated | Sunitinib Before and After Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed By S NCT00747305 | Harry Drabkin | Phase 1 |
| Terminated | Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Mali NCT00788125 | City of Hope Medical Center | Phase 1 / Phase 2 |
| Withdrawn | Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone Metastases NCT00769990 | Masonic Cancer Center, University of Minnesota | Phase 1 / Phase 2 |
| Completed | Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smokin NCT00790569 | Butler Hospital | N/A |
| Completed | Warm Ischemia or Cold Ischemia During Surgery in Treating Patients With Stage I Kidney Cancer NCT00743236 | Wake Forest University Health Sciences | N/A |
| Recruiting | Autologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic Tumors NCT00722228 | Hadassah Medical Organization | Phase 1 / Phase 2 |
| Terminated | Sorafenib in Treating Patients With Locally Advanced or Metastatic Kidney Cancer NCT00727532 | Northwestern University | N/A |
| Completed | Anti-IMP3 Autoantibody and MicroRNA Signature Blood Tests in Finding Metastasis in Patients With Localized or NCT00806650 | City of Hope Medical Center | — |
| Unknown | Sunitinib Before and After Surgery in Treating Patients With Stage IV Kidney Cancer NCT00717587 | Abramson Cancer Center at Penn Medicine | Phase 2 |
| Terminated | Gene-Modified Lymphocytes, High-Dose Aldesleukin, and Vaccine Therapy in Treating Patients With Progressive or NCT00704938 | National Institutes of Health Clinical Center (CC) | Phase 2 |
| Withdrawn | Studying Tumor Tissue Samples From Patients Who Have Undergone Surgery for Localized Kidney Cancer NCT00908739 | Case Comprehensive Cancer Center | — |
| Completed | Cancer Development In Organ Transplant Recipients NCT02333279 | University of Zurich | — |
| Completed | Study of MDX-1411 Given Every 14 Days With Pre-medications to Subjects With Clear Cell Kidney Cancer. NCT00656734 | Bristol-Myers Squibb | Phase 1 |
| Unknown | MRI Scans of Blood Vessel Changes Caused by Bevacizumab Alone or Given Together With Interferon Alpha-2a in Tr NCT00873236 | Mount Vernon Cancer Centre at Mount Vernon Hospital | Phase 2 |
| Completed | Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma NCT00659568 | London Health Sciences Centre | Phase 1 |
| Completed | Evaluating Renal Masses Using Ultrasound Intravenous Microbubble Contrast NCT00671411 | Memorial Sloan Kettering Cancer Center | Phase 1 |
| Completed | Pre-surgical Detection of Clear Cell Renal Cell Carcinoma (ccRCC) Using Radiolabeled G250-Antibody NCT00606632 | Heidelberg Pharma AG | Phase 3 |
| Terminated | Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer NCT00601926 | Paul Monk | Phase 2 |
| Unknown | Sunitinib Before or After Surgery in Treating Patients With Metastatic Kidney Cancer NCT00626509 | Gruppo Italiano Carcinoma Renale | Phase 2 |
| Terminated | Cryoablation or External-Beam Radiation Therapy in Treating Patients With Painful Bone Metastases NCT00540969 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Terminated | PEG-Interferon Alfa-2b and Sorafenib in Treating Patients With Unresectable or Metastatic Kidney Cancer NCT00589550 | Thomas Olencki | Phase 1 |
| Unknown | Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the NCT00757614 | Cancer Research UK | — |
| Active Not Recruiting | A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 ( NCT00600496 | AstraZeneca | Phase 1 |
| Completed | Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking NCT00666978 | Lisa Sanderson Cox, PhD | Phase 4 |
| Unknown | Ultrasound in Assessing Antiangiogenic Treatment in Patients With Advanced Kidney Cancer NCT01105364 | National Cancer Institute, France | N/A |
| Completed | Safety and Toxicity Study of Sorafenib in Patients With Kidney Cancer NCT00854620 | Stanford University | Phase 2 |
| Completed | Biomarkers That Predict Response to High-Dose Aldesleukin in Metastatic Kidney Cancer or Metastatic Melanoma NCT00617799 | University of Nebraska | — |
| Terminated | Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the Brain NCT00550654 | National Institutes of Health Clinical Center (CC) | Phase 2 |
| Completed | Sunitinib as First-Line Therapy in Treating Patients With Locally Advanced Metastatic Papillary Renal Cell Can NCT00541008 | UNICANCER | Phase 2 |
| Terminated | Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical NCT00896467 | Centre Oscar Lambret | — |
| Completed | Sunitinib Malate Before and After Surgery in Treating Patients With Previously Untreated Metastatic Kidney Can NCT01024205 | Barts and the London School of Medicine and Dentistry | Phase 2 |
| Completed | Sunitinib and Surgery in Treating Patients With Localized or Metastatic Kidney Cancer NCT00849186 | Roswell Park Cancer Institute | N/A |
| Completed | DNA Analysis of Blood and/or Tissue Samples From Patients With Primary Kidney Cancer Receiving Sorafenib on Cl NCT00900536 | Medical Research Council | — |
| Completed | Capecitabine, Gemcitabine, and Bevacizumab in Combination for Patients With Sarcomatoid Renal Cell Carcinoma NCT00496587 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Ph II Study of Perifosine for Patients With Carcinoma of the Kidney NCT00498966 | AEterna Zentaris | Phase 2 |
| Completed | Sorafenib in Treating Patients at Risk of Relapse After Undergoing Surgery to Remove Kidney Cancer NCT00492258 | Medical Research Council | Phase 3 |
| Terminated | Interleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney Cancer NCT00492440 | Cytheris SA | Phase 1 |
| Completed | Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer NCT00369564 | University of South Florida | Phase 3 |
| Completed | Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Tr NCT00787761 | Northside Hospital, Inc. | Phase 2 |
| Terminated | Sorafenib in Treating Patients With Metastatic or Unresectable Kidney Cancer NCT00496756 | University of Nebraska | Phase 2 |
| Completed | Sunitinib in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer NCT00459875 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | Sunitinib in Treating Patients With Kidney Cancer That Cannot Be Removed by Surgery NCT00459979 | Case Comprehensive Cancer Center | Phase 2 |
| Completed | Sunitinib in Treating Patients With Brain Metastases Caused by Kidney Cancer or Melanoma NCT00462982 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors NCT00620295 | Masonic Cancer Center, University of Minnesota | Phase 1 |
| Completed | Sunitinib Malate in Patients With Non-Clear Cell Renal Cell Cancer NCT00465179 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Radiosurgery in Treating Patients With Kidney Tumors NCT00458484 | Case Comprehensive Cancer Center | N/A |
| Completed | High-dose Bevacizumab in Advanced Renal Carcinoma Patients NCT00455975 | SCRI Development Innovations, LLC | Phase 2 |
| Withdrawn | Stereotactic Radiation Therapy in Treating Patients With Kidney Tumors NCT00445757 | Case Comprehensive Cancer Center | Phase 1 |
| Withdrawn | Talabostat in Treating Patients With Metastatic Kidney Cancer NCT00489710 | University of Nebraska | Phase 2 |
| Completed | Dosing and Effectiveness Study of Sorafenib and RAD001 in the Treatment of Patients With Advanced Kidney Cance NCT00392821 | SCRI Development Innovations, LLC | Phase 1 / Phase 2 |
| Completed | Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer NCT00436410 | National Institutes of Health Clinical Center (CC) | EARLY_Phase 1 |
| Completed | Sorafenib in Treating Patients Undergoing Surgery for Stage II, Stage III, or Stage IV Kidney Cancer NCT00405366 | UNC Lineberger Comprehensive Cancer Center | EARLY_Phase 1 |
| Completed | Zoledronate With Atorvastatin in Renal Cell Carcinoma NCT00490698 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | A Study of RAD001 and Sunitinib in Metastatic Renal Cell Carcinoma NCT00422344 | Memorial Sloan Kettering Cancer Center | Phase 1 |
| Completed | Sunitinib and Erlotinib in Treating Patients With Unresectable or Metastatic Kidney Cancer NCT00425386 | OHSU Knight Cancer Institute | Phase 2 |
| Completed | Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy Participants NCT00900276 | Wake Forest University Health Sciences | — |
| Completed | Paclitaxel and Carboplatin in Treating Patients With Locally Advanced or Metastatic Renal Cell Cancer NCT00077129 | Eastern Cooperative Oncology Group | Phase 2 |
| Completed | Bevacizumab (Avastin) and RAD001(Everolimus)in the Treatment of Advanced Clear Cell Renal Carcinoma NCT00323739 | SCRI Development Innovations, LLC | Phase 2 |
| Terminated | Gemcitabine With or Without Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Canc NCT00323791 | University of Medicine and Dentistry of New Jersey | Phase 2 |
| Completed | Positron Emission Tomography and CT Scan in Predicting Response in Patients With Metastatic Melanoma or Kidney NCT00316901 | National Institutes of Health Clinical Center (CC) | Phase 2 |
| Completed | Bortezomib in Treating Patients With Metastatic Kidney Cancer NCT00276614 | Jonsson Comprehensive Cancer Center | Phase 2 |
| Completed | A Phase I Study of Bevacizumab and Sunitinib in Metastatic Renal Cell Carcinoma Patients NCT00421512 | Memorial Sloan Kettering Cancer Center | Phase 1 |
| Withdrawn | Early Enteral Tube Feedings in Children Receiving Chemo for AML/MDS & High Risk Solid Tumors NCT00624962 | Vanderbilt University | N/A |
| Completed | Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking NCT00365508 | Fox Chase Cancer Center | Phase 4 |
| Completed | Sorafenib in Treating Patients With Metastatic Kidney Cancer That Has Not Responded to Sunitinib or Bevacizuma NCT00866320 | Case Comprehensive Cancer Center | Phase 2 |
| Completed | Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung Cancer NCT00514215 | Barbara Ann Karmanos Cancer Institute | Phase 2 |
| Completed | Adoptive Immunotherapy, Aldesleukin, and Zoledronate in Treating Patients With Stage IV Kidney Cancer and Lung NCT00588913 | Tokyo Women's Medical University | Phase 1 / Phase 2 |
| Completed | Everolimus and Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer NCT00331409 | OHSU Knight Cancer Institute | Phase 2 |
| Completed | Bupropion in Helping Adults Stop Smoking NCT00534001 | Roswell Park Cancer Institute | Phase 2 |
| Completed | Bevacizumab and Aldesleukin in Treating Patients With Metastatic Clear Cell Carcinoma of the Kidney NCT00853021 | Jorge A. Garcia, MD | Phase 2 |
| Completed | Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Br NCT00303940 | National Institutes of Health Clinical Center (CC) | Phase 1 |
| Unknown | Tinzaparin in Treating Patients With Metastatic Kidney Cancer That Cannot Be Removed By Surgery NCT00293501 | University of Vermont | Phase 1 / Phase 2 |
| Terminated | Comparison of Immune Response Following Surgical Management of Renal Tumors NCT00289146 | Emory University | — |
| Completed | Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors NCT00622674 | Masonic Cancer Center, University of Minnesota | Phase 1 |
| Completed | Sorafenib in Treating Patients With Kidney Cancer That Has Spread to the Brain NCT00301847 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Genistein and Interleukin-2 in Treating Patients With Metastatic Melanoma or Kidney Cancer NCT00276835 | Northwestern University | EARLY_Phase 1 |
| Unknown | Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer NCT00301990 | Jonsson Comprehensive Cancer Center | Phase 2 |
| Terminated | MT2004-30: Tomotherapy for Solid Tumors NCT00623077 | Masonic Cancer Center, University of Minnesota | Phase 1 |
| Completed | Treatment of Patients With Advanced Renal Cancer With a Radiolabeled Antibody, Yttrium-90 Conjugated Chimeric NCT00199875 | Ludwig Institute for Cancer Research | Phase 1 |
| Unknown | Polyvinylpyrrolidone-Sodium Hyaluronate Gel in Reducing Pain From Oral Mucositis in Young Patients With Cancer NCT00349024 | Children's Cancer and Leukaemia Group | N/A |
| Terminated | Fludarabine and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant fo NCT00243009 | OHSU Knight Cancer Institute | Phase 2 |
| Completed | Safety Study With the Antibody, cG250, and Isotope, 124-Iodine, to Diagnose Patients With Renal Masses. NCT00199888 | Ludwig Institute for Cancer Research | Phase 1 |
| Terminated | Clinical Trial Studying a Personalized Cancer Vaccine in Patients With Non-metastatic Kidney Cancer NCT00126178 | Agenus Inc. | Phase 3 |
| Unknown | Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic NCT00295997 | University of California, San Francisco | N/A |
| Completed | Pilot Study of Denileukin Diftitox Plus High-Dose IL-2 for Patients With Metastatic Renal Cancer NCT00278369 | Northwestern University | EARLY_Phase 1 |
| Completed | Interferon Alfa (IFN-Alpha-1b) in Renal Cancer With Metastatic Kidney Cancer NCT00278174 | Case Comprehensive Cancer Center | Phase 2 |
| Completed | Neoadjuvant Clinical Trial to Evaluate the Efficacy of Bevacizumab for Renal Cell Carcinoma NCT00113217 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Vatalanib and Everolimus in Treating Patients With Advanced Solid Tumors NCT00303732 | Daniel George, MD | Phase 1 |